Basal, endogenous leptin is metabolically active in newborn rat pups

Area of Science:

• Neuroendocrinology
• Metabolic Regulation
• Developmental Biology

Background:

• Leptin, an adipocyte-derived hormone, regulates energy balance in adults via the JAK-STAT pathway in hypothalamic neurons.
• Investigating leptin's role in neonates is crucial for understanding early metabolic programming.

Purpose of the Study:

• To determine if endogenous leptin is metabolically active in newborn rat pups.
• To analyze the JAK-STAT leptin signaling pathway in response to leptin antagonist challenge.

Main Methods:

• One-day-old male rat pups were injected with saline, leptin, a leptin antagonist (PEG-MLA), or leptin plus PEG-MLA.
• Hypothalami were dissected at 30, 45, and 60 minutes post-injection.
• Protein expression of ObR, STAT3, pSTAT3, and SOCS3 was assessed using Western blot analysis.

Main Results:

• Leptin administration significantly increased hypothalamic pSTAT3 levels compared to saline.
• The leptin antagonist PEG-MLA effectively blocked leptin's induction of JAK-STAT signaling.
• Co-administration of leptin and PEG-MLA attenuated the leptin-induced increase in pSTAT3.

Conclusions:

• Basal leptin levels are metabolically active in newborn rats.
• These findings highlight the importance of endogenous leptin at birth for neurodevelopment and metabolic health.
• Results offer potential therapeutic avenues for programmed or diet-induced obesity, particularly in low birth weight infants.